Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes

J Alzheimers Dis. 2016 May 4;53(2):445-9. doi: 10.3233/JAD-160073.

Abstract

Progranulin gene (GRN) mutations are characterized by heterogeneous presentations. Corticobasal syndrome (CBS) is often associated with GRN mutations, whereas association with progressive supranuclear palsy syndrome (PSPS) is rare. Plasma progranulin levels were evaluated in 34 patients, including 19 with PSPS, 12 with CBS, and 3 with mixed signs, with the purpose to screen for the presence of causal mutations, associated with low levels. We found undetectable levels in a patient with CBS. Sequencing confirmed the presence of the Thr272fs deletion. Progranulin mutation screening is suggested in cases of CBS, even in the absence of positive family history for dementia and/or movement disorders.

Keywords: Corticobasal syndrome; TDP-43; progranulin; progressive supranuclear palsy syndrome; tau.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Brain Diseases / blood*
  • Brain Diseases / diagnostic imaging
  • Brain Diseases / genetics*
  • DNA-Binding Proteins / metabolism
  • Female
  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Genotype
  • Humans
  • Intercellular Signaling Peptides and Proteins / blood*
  • Intercellular Signaling Peptides and Proteins / genetics*
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Positron-Emission Tomography
  • Progranulins
  • Supranuclear Palsy, Progressive / blood*
  • Supranuclear Palsy, Progressive / diagnostic imaging
  • Supranuclear Palsy, Progressive / genetics*

Substances

  • DNA-Binding Proteins
  • GRN protein, human
  • Intercellular Signaling Peptides and Proteins
  • Progranulins
  • TARDBP protein, human
  • Fluorodeoxyglucose F18